Abstract
Overview
Introduction
Latin American countries have attracted a lot of attention recently. With
their economies currently stable, their geographic location and low-cost is
ideal for investors. In addition, having such a high and varied population
eases recruitment for clinical trials, and the demographics show there is a
very high need for pharmaceuticals.
Scope
- Overview of the key trends driving the pharmaceutical market growth
- Analysis of key healthcare system characteristics impacting the
pharmaceutical market
- Analysis of pharmaceutical market dynamics in Argentina and Mexico
- Overview of key pharmaceutical players in Argentina and Mexico
Highlights
Although both the Argentinean and the Mexican markets have been growing, their
growth is attributed to different reasons. The Argentinean pharmaceutical
market has been growing mainly based on growing sales volume, while growth of
the Mexican market is mainly driven by growing prices.
The Mexican market is dominated by foreign companies with few domestic
players. The Argentinean market is dominated by domestic branded generics
firms, due to the economic crisis which led to many foreign companies to sell
their plants in Argentina, thus allowing the domestic firms to gain over their
market share.
Sales of pharmaceutical categories in both countries are very similar to the
West thus opening growth opportunities for foreign companies. However, sales
of oncology drugs are low in both countries; and Mexico has higher sales of
anti-infective drugs indicating that these markets still have scope for
further development and growth.
Reasons to Purchase
- Identify the healthcare needs in Argentina and Mexico
- Understand the barriers and drivers for entering these markets
- Gain insight into pharmaceutical dynamics of Argentina and Mexico
View Cart
